Bioinformatics methods for learning radiation-induced lung inflammation from heterogeneous retrospective and prospective data.
Radiotherapy outcomes are determined by complex interactions between physical and biological factors, reflecting both treatment conditions and underlying genetics. Recent advances in radiotherapy and biotechnology provide new opportunities and challenges for predicting radiation-induced toxicities, particularly radiation pneumonitis (RP), in lung cancer patients. In this work, we utilize datamining methods based on machine learning to build a predictive model of lung injury by retrospective analysis of treatment planning archives. In addition, biomarkers for this model are extracted from a prospective clinical trial that collects blood serum samples at multiple time points. We utilize a 3-way proteomics methodology to screen for differentially expressed proteins that are related to RP. Our preliminary results demonstrate that kernel methods can capture nonlinear dose-volume interactions, but fail to address missing biological factors. Our proteomics strategy yielded promising protein candidates, but their role in RP as well as their interactions with dose-volume metrics remain to be determined.
Spencer
Sarah J
SJ
Department of Radiation Oncology, Washington University Medical School, Saint Louis, MO 63110, USA.
Bonnin
Damian Almiron
DA
Deasy
Joseph O
JO
Bradley
Jeffrey D
JD
El Naqa
Issam
I
D002289:Carcinoma, Non-Small-Cell Lung / Q000378:metabolism / Q000532:radiotherapy*; D019295:Computational Biology / Q000379:methods*; D004307:Dose-Response Relationship, Radiation; D006801:Humans; D008175:Lung Neoplasms / Q000378:metabolism / Q000532:radiotherapy*; D008954:Models, Biological; D025341:Principal Component Analysis; D011446:Prospective Studies; D040901:Proteomics / Q000379:methods; D017564:Radiation Pneumonitis / Q000209:etiology* / Q000378:metabolism; D011878:Radiotherapy / Q000009:adverse effects; D012189:Retrospective Studies
Proteomics. 2002 Oct;2(10):1374-91
12422355
Clin Oncol (R Coll Radiol). 2007 Aug;19(6):470-80
17419040
Int J Radiat Oncol Biol Phys. 2001 Nov 15;51(4):1064-80
11704332
Med Phys. 2002 Sep;29(9):2109-27
12349932
Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1275-86
16504765
IEEE Trans Med Imaging. 2002 Dec;21(12):1552-63
12588039
Semin Radiat Oncol. 2007 Oct;17(4):293-7
17903707
Phys Med Biol. 2006 Nov 21;51(22):5719-35
17068361
Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):112-24
16618575
IEEE Trans Med Imaging. 2004 Oct;23(10):1233-44
15493691
Semin Oncol. 2005 Apr;32(2 Suppl 3):S42-54
16015535
Comb Chem High Throughput Screen. 2005 Dec;8(8):717-23
16464158
Semin Radiat Oncol. 2008 Apr;18(2):75-88
18314062
Biochim Biophys Acta. 1975 Oct 20;405(2):442-51
1180967
Int J Radiat Oncol Biol Phys. 2000 Jul 15;47(5):1245-60
10889378
Int J Radiat Oncol Biol Phys. 2005 Jul 1;62(3):829-37
15936567
Semin Radiat Oncol. 2008 Oct;18(4):240-3
18725110
Med Phys. 2003 May;30(5):979-85
12773007
Nat Methods. 2007 Oct;4(10):787-97
17901868
Semin Radiat Oncol. 2008 Apr;18(2):115-25
18314066
Semin Surg Oncol. 2003;21(3):205-19
14508854
Cancer Treat Res. 2008;139:215-56
18236719
Int J Radiat Oncol Biol Phys. 2002 Oct 1;54(2):313-6
12243802